AIRLINK 177.92 Increased By ▲ 0.92 (0.52%)
BOP 12.88 Increased By ▲ 0.07 (0.55%)
CNERGY 7.58 Increased By ▲ 0.09 (1.2%)
FCCL 45.99 Increased By ▲ 3.97 (9.45%)
FFL 15.16 Increased By ▲ 0.32 (2.16%)
FLYNG 27.34 Decreased By ▼ -0.36 (-1.3%)
HUBC 132.04 Decreased By ▼ -2.47 (-1.84%)
HUMNL 13.29 Increased By ▲ 0.33 (2.55%)
KEL 4.46 Increased By ▲ 0.02 (0.45%)
KOSM 6.06 No Change ▼ 0.00 (0%)
MLCF 56.63 Increased By ▲ 2.12 (3.89%)
OGDC 223.84 Increased By ▲ 1.26 (0.57%)
PACE 5.99 Decreased By ▼ -0.04 (-0.66%)
PAEL 41.51 Increased By ▲ 0.21 (0.51%)
PIAHCLA 16.01 Increased By ▲ 0.39 (2.5%)
PIBTL 9.88 Decreased By ▼ -0.18 (-1.79%)
POWER 11.16 Decreased By ▼ -0.01 (-0.09%)
PPL 186.63 Increased By ▲ 2.64 (1.43%)
PRL 34.90 Increased By ▲ 0.59 (1.72%)
PTC 23.53 Increased By ▲ 0.19 (0.81%)
SEARL 94.96 Increased By ▲ 3.89 (4.27%)
SILK 1.14 Increased By ▲ 0.03 (2.7%)
SSGC 35.50 Increased By ▲ 1.52 (4.47%)
SYM 15.64 Decreased By ▼ -0.32 (-2.01%)
TELE 7.87 Increased By ▲ 0.01 (0.13%)
TPLP 10.93 Decreased By ▼ -0.08 (-0.73%)
TRG 59.20 Increased By ▲ 0.48 (0.82%)
WAVESAPP 10.78 Decreased By ▼ -0.01 (-0.09%)
WTL 1.35 Decreased By ▼ -0.01 (-0.74%)
YOUW 3.80 Decreased By ▼ -0.01 (-0.26%)
AIRLINK 177.92 Increased By ▲ 0.92 (0.52%)
BOP 12.88 Increased By ▲ 0.07 (0.55%)
CNERGY 7.58 Increased By ▲ 0.09 (1.2%)
FCCL 45.99 Increased By ▲ 3.97 (9.45%)
FFL 15.16 Increased By ▲ 0.32 (2.16%)
FLYNG 27.34 Decreased By ▼ -0.36 (-1.3%)
HUBC 132.04 Decreased By ▼ -2.47 (-1.84%)
HUMNL 13.29 Increased By ▲ 0.33 (2.55%)
KEL 4.46 Increased By ▲ 0.02 (0.45%)
KOSM 6.06 No Change ▼ 0.00 (0%)
MLCF 56.63 Increased By ▲ 2.12 (3.89%)
OGDC 223.84 Increased By ▲ 1.26 (0.57%)
PACE 5.99 Decreased By ▼ -0.04 (-0.66%)
PAEL 41.51 Increased By ▲ 0.21 (0.51%)
PIAHCLA 16.01 Increased By ▲ 0.39 (2.5%)
PIBTL 9.88 Decreased By ▼ -0.18 (-1.79%)
POWER 11.16 Decreased By ▼ -0.01 (-0.09%)
PPL 186.63 Increased By ▲ 2.64 (1.43%)
PRL 34.90 Increased By ▲ 0.59 (1.72%)
PTC 23.53 Increased By ▲ 0.19 (0.81%)
SEARL 94.96 Increased By ▲ 3.89 (4.27%)
SILK 1.14 Increased By ▲ 0.03 (2.7%)
SSGC 35.50 Increased By ▲ 1.52 (4.47%)
SYM 15.64 Decreased By ▼ -0.32 (-2.01%)
TELE 7.87 Increased By ▲ 0.01 (0.13%)
TPLP 10.93 Decreased By ▼ -0.08 (-0.73%)
TRG 59.20 Increased By ▲ 0.48 (0.82%)
WAVESAPP 10.78 Decreased By ▼ -0.01 (-0.09%)
WTL 1.35 Decreased By ▼ -0.01 (-0.74%)
YOUW 3.80 Decreased By ▼ -0.01 (-0.26%)
BR100 12,130 Increased By 107.3 (0.89%)
BR30 37,246 Increased By 640.2 (1.75%)
KSE100 114,399 Increased By 685.5 (0.6%)
KSE30 35,458 Increased By 156.2 (0.44%)

PARIS: French President Emmanuel Macron warned Thursday about the lack of information about China's coronavirus vaccines, saying they might even encourage the development of variants if they are not effective.

Speaking to the Atlantic Council think-tank, Macron conceded that China's early "diplomatic successes" in distributing vaccines to other countries could be seen as "a little bit humiliating for us as (Western) leaders".

But he warned that the efficacy of a jab from Sinopharma or Sinovac was unknown because "absolutely no information" has been shared about trials.

"What it means is that in the medium to long run it is almost sure that if this vaccine is not appropriate it will facilitate the emergence of new variants, it will absolutely not fix the situation of these countries," he said.

His comment came a day after European Commission chief Ursula von der Leyen also urged Russia and China to "show all the data" if they want their vaccines to be approved in the European Union.

Last Friday, Macron also cast doubt on a vaccine produced by British-Swedish group AztraZeneca, saying it appeared not to be effective for people over 65 years of age - despite European regulators approving it for adults of all ages.

There has been dismay in France after the country's top pharma group Sanofi and leading research centre the Pasteur Institute suffered setbacks in their efforts to developed a vaccine.

The hunt for vaccines against Covid-19 have seen nations compete to devise and distribute jabs to other countries as a way of increasing their diplomatic and economic clout, as well as their prestige. Hungary and Serbia are set to use the Sinopharm vaccine in Europe, while Beijing is also donating or selling to countries around the world from Pakistan to Turkey, the United Arab Emirates and West African nations. Speaking in favour of a Western-led multilateral approach, Macron said he believed that "in the very long run we can be more efficient".

The French leader also urged the US-led NATO military alliance, which has been historically focused on defence against Russia, to discuss "how to deal with new Pacific issues" which he said meant China.

"This is a question. This is the elephant in the room. We have to speak very clearly about this issue. My willingness is to have a political approach, because I want a stable and peaceful world," he said.

China was the source of the coronavirus pandemic after a novel strain of coronavirus emerged in the city of Wuhan in late 2019.

Comments

Comments are closed.